Diltiazem and verapamil are two non-dihydropyridine calcium channel blockers (non-DHP CCBs) most commonly used in managing certain cardiac conditions. Even though they fall into the same medication class, these medications have important pharmacological differences...
It can be overwhelming walking into the pharmacy and looking down the vitamin aisle – especially when you finally find a specific supplement, only to discover there are numerous forms lining the shelves. This gets even more challenging when you don’t know which salt...
This video is part of a three-part series covering new literature that could influenceclinical practice. In this video, I discuss the combined usage of antiplatelets with DOACsin patients with ASCVD risk and atrial fibrillation. Each mechanism of action is reviewed,as...
This video is part of a three-part series covering new literature that could influence clinical practice. In this video, I discuss whether beta-blocker use post-MI is beneficial for patients with HFpEF. Background about the mechanism of action and typical place in...
This video is part of a three-part series covering new literature that could influence clinical practice. Finerenone has been studied in the setting of HFpEF and I review this topic. More specifically, in this video, I discuss the background of why finerenone may be...
